Funding · Company
SeLux Diagnostics, Inc.
Charlestown, MABiotech & Pharma
SeLux Diagnostics, Inc. of Charlestown, MA has disclosed $88M across 2 Form D offerings filed with the SEC between Feb 28, 2022 and Feb 13, 2024.
$88M
Total disclosed
2
Form D offerings
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$40M
Form D · Feb 13, 2024 ↗
Q1 2024
· target $45M
$48M
Form D · Feb 28, 2022 ↗
Q1 2022
· target $58M
Filing details
HeadquartersCharlestown, MAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001736293Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →